Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Huh

Showing results (351-360 of 365) with videos related to

Pageof 37
Sort By:
The Lancet. Oncology|April 20, 2023
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trialLinda R Mileshkin, Kathleen N Moore, Elizabeth H Barnes, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2014
Uterine neoplasms, version 1.2014Wui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 15, 2015
Cervical Cancer, Version 2.2015Wui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 15, 2013
Cervical cancerWui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2019
Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyNadeem R Abu-Rustum, Catheryn M Yashar, Sarah Bean, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 6, 2020
NCCN Guidelines Insights: Cervical Cancer, Version 1.2020Nadeem R Abu-Rustum, Catheryn M Yashar, Sarah Bean, et al.
Lancet (London, England)|September 10, 2017
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trialWarner K Huh, Elmar A Joura, Anna R Giuliano, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2015
Uterine Sarcoma, Version 1.2016: Featured Updates to the NCCN GuidelinesWui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.
Obstetrics and Gynecology|July 12, 2018
Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of AgeSuzanne M Garland, Elmar A Joura, Kevin A Ault, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 20, 2019
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in OncologyWui-Jin Koh, Nadeem R Abu-Rustum, Sarah Bean, et al.
Pageof 37

Showing results (351-360 of 365) with videos related to

Sort By:
Pageof 37
The Lancet. Oncology|April 20, 2023
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trialLinda R Mileshkin, Kathleen N Moore, Elizabeth H Barnes, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2014
Uterine neoplasms, version 1.2014Wui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 15, 2015
Cervical Cancer, Version 2.2015Wui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 15, 2013
Cervical cancerWui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2019
Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyNadeem R Abu-Rustum, Catheryn M Yashar, Sarah Bean, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 6, 2020
NCCN Guidelines Insights: Cervical Cancer, Version 1.2020Nadeem R Abu-Rustum, Catheryn M Yashar, Sarah Bean, et al.
Lancet (London, England)|September 10, 2017
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trialWarner K Huh, Elmar A Joura, Anna R Giuliano, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2015
Uterine Sarcoma, Version 1.2016: Featured Updates to the NCCN GuidelinesWui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.
Obstetrics and Gynecology|July 12, 2018
Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of AgeSuzanne M Garland, Elmar A Joura, Kevin A Ault, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 20, 2019
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in OncologyWui-Jin Koh, Nadeem R Abu-Rustum, Sarah Bean, et al.
Pageof 37